Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Collaboration: Page 4
Capitainer, University of Florida to develop quantitative dried blood spot-sampling technology
The collaboration aims to accelerate the development of necessary laboratory tools to address a shortage of clinical laboratories and methods for at-home collection of microsamples.
October 6, 2022
Guardian Research Network, Northeast Georgia Health partner on clinical research, patient treatment
GRN, whose activities include testing for early cancer diagnosis, said the collaboration aims to enable innovation in clinical research and patient treatment for local, rural, and suburban communities.
September 30, 2022
Epicore announces partnership with 3M and Innovize to scale portfolio of wearable hydration solutions
Wearable solutions developer Epicore Biosystems on Thursday announced a partnership with 3M’s Health Care Business and Innovize to scale the development of its sweat-sensing wearable technology.
September 29, 2022
PathAI partners with Roche for AI tech
The companies said the partnership allows for broad access to digital pathology diagnostics to support clinical research and companion diagnostic programs globally.
October 14, 2021
MD Anderson, BostonGene enter into strategic alliance
The agreement expands upon existing research collaborations between BostonGene and multiple center researchers. MD Anderson and BostonGene will work together on clinical utility studies designed to support incorporating BostonGene testing into national guidelines and adoption as a national standard of care.
September 30, 2021
Group forms to evaluate early cancer detection tests
MCED tests use blood draws, urine, saliva, or stool samples to rapidly screen for multiple types of cancer at once, potentially catching and treating disease earlier. The consortium will evaluate the clinical and public health value of the tests for earlier cancer detection and treatment and establish standards for their use in routine medical care.
April 22, 2021
Study revises thinking on genes and breast cancer risk
The review incorporates the findings of the Cancer Risk Estimates Related to Susceptibility (CARRIERS) consortium, a group evaluating predisposition genes and the incidence of breast cancer. Drawing from U.S. population studies, researchers evaluated hereditary cancer genetic testing for 12 established breast cancer genes in a total of 32,247 women with breast cancer and 32,544 women without breast cancer. Results were published by Fergus Couch, PhD, a consultant in experimental pathology and laboratory medicine at the Mayo Clinic, and colleagues.
January 21, 2021
Pershing Square Foundation funds SARS-CoV-2 research
The researchers typically focus on cancer research but are instead using their expertise to better understand SARS-CoV-2, the virus that causes COVID-19. The winning projects include a variety of research topics related to COVID-19 and SARS-CoV-2, including potential treatments, genetic or immune determinants, and testing.
July 7, 2020
Is whole genome sequencing for children with rare diseases worth the price?
WGS has been proposed as a possible shortcut out of the "diagnostic odyssey," the ordeal endured by patients with rare diseases as they undergo a seemingly endless series of clinical evaluations, imaging studies, and laboratory tests before obtaining a diagnosis.
June 29, 2020
San Diego research institutes study spread of COVID-19
The new collaboration is called the San Diego Epidemiology and Research for COVID Health (SEARCH) alliance. The cross-institutional group is co-led by clinical researchers at Rady Children's Hospital-San Diego, Rady Children's Institute for Genomic Medicine, Scripps Research, and the University of California (UC), San Diego.
June 15, 2020
Taking time out for genetic testing in acute myeloid leukemia may be OK
The retrospective real-world study evaluated outcomes for AML patients included in the Study Alliance Leukemia (SAL) AML registry, which includes 46 treatment centers in Germany. Researchers set out to evaluate how differences in the length of time from diagnosis to start of treatment correlated with overall survival and other key outcomes in patients newly diagnosed with and previously untreated for AML.
June 4, 2020
Neurofilament light blood test shows concussion damage in study of veterans
Sponsored by grant funding from the U.S. Department of Defense (DOD) Chronic Effects of Neurotrauma Consortium (CENC), the study evaluated levels of the protein NfL in blood tests and how they correlated with concussion in 195 military veterans. Researchers found higher levels in veterans with a history of three or more concussions compared to those who had not had mTBI. In addition, high NfL was associated with more severe symptoms such as post-traumatic stress disorder (PTSD) and depression.
May 27, 2020
Previous Page
Page 4 of 5
Next Page
